1.The effect of modified Morita therapy on depression
Chinese Journal of Behavioral Medicine and Brain Science 2008;17(6):545-547
Objective To investigate the assistant effect of modified Morita therapy on depression. Methods 60 outpatients of depression were selected and grouped by registration order,research group (RG) was given antidepressant and Morita therapy,control group (CG) as antidepressant. Scales HAMD and SF-36 were evaluated before treatment and after 12 weeks. Results There was no significant difference on sex,age,marriage,education,scores of HAMD and SF-36 between two groups ( P> 0.05 ). After treatment, HAMD and SF-36 of two groups were improved notably (P<0.01). HAMD(RG:7.60±5.76,CG:13.70±8.46, P<0. O1) and GH(RG:68.13 ±15.77,CG:59.00 ± 17.12, P<0.05) ,VT( RG:68.83 ± 18.67 ,CG:47.17 ± 18.18, P<0. 01 ) ,SF( RG:86.23± 18.67,CG:77.03 ±12.28, P<0.01) ,RE(RG:74.44 ± 35.76,CG:51.12 ±41.74, P<0.05) ,MH (RG:75.47 ± 16.16, CG :61.73 ± 15.75, P< 0.01 ) of SF-36 in research group were improved significantly than those in control group. Conclusion Modified Morita therapy could increase the effect of antidepressants and improve outcome of diseases.
2.The research of relationship of pre- and post-menopausal periods and menopausal-age limit with blood lipid level in hypertensive women
Naizhen ZHOU ; Zhiqing CHEN ; Zuowei ZHANG
Chinese Journal of Geriatrics 2003;0(09):-
Objective To investigate the effect of pre- and post-menopausal periods and menopausal-age limit on lipid metabolism in hypertensive women. Methods One hundred thirty-one hypertensive women in pre- or post-menopausal periods were collected for the determination of blood triglycerides(TG),total cholesterol(TC),high density lipoprotein cholesterol(HDL-C)and low density lipoprotein(LDL-C). The blood lipid levels were compared between hypertensive and control groups,as well as between pre- and post-menopausal subgroups,and the relationship between menopausal-age limit and blood levels lipid was analyzed. Results Hypertensive group in pre-menopausal period had significantly higher TC and LDL-C than did the control group〔TC,(5.27?0.47)vs(4.33?0.70)mmol/L;LDL-C,(3.50?0.45)vs(2.67?0.50)mmol/L respectively, all P
3.Clinical analysis of treatment of ~(131) iodine combined with Jiakangsha oral solution in 230 cases with hyperthyroidism
Yiling GUO ; Yingnan ZHANG ; Zuowei CHEN ; Zuoba XIN
Chinese Journal of Primary Medicine and Pharmacy 2010;17(2):154-155
Objective To observe the treatment efficacy in patients with hyperthyroidism by ~(131) radioactive iodine in conjunction with Jiakangshu oral solution.Methods 465 cases with hyperthyroidism were divided into control group(n=235)and treatment group(n=230).In the treatment group on the basis of ~(131) iodine therapy plus service Jiakangshu oral solution.The contents of T_3,T_4,FT_3,FT_4,TSH were observed before and after treatment.Results The cure rate 74.7% in treatment group after treatment 12-month was higher than 65.1%(χ~2=3.94,P<0.05),total effective rate 88.6% was higher than 80.4%(χ~2=3.90,P<0.05).The contents of T_3,T_4,FT_3,FT_4,TSH drop,but TSH levels increased in two groups after 12 months with those before treatment(t=2.745,2.778,2.845,2.812,2.833,all P<0.05).The contents of T_3,T_4,FT_3,FT_4 in treatment group decreased significantly compared with the control group after treatment 12 months(t=2.145,2.178,2.245,all P<0.05).The negative conversion rate of TGAb,TMAb in the treatment group were significantly higher than control group(χ~2=3.98,3.88,all P<0.05).Conclusion The treatment effecs are obvious in patients with hyperthyroidism by 131 radioactive iodine in conjunction with JiaKangShu oral solution.
4.Follow-up value of the detection of thyroglobulin and whole body scan by 131I for thyroid cancer after treatment by 131I
Yiling GUO ; Yingnan ZHANG ; Zuowei CHEN ; Cheng FENG ; Zhenbo XIN
Chinese Journal of Primary Medicine and Pharmacy 2013;20(9):1281-1283
Objective To explore the value of follow-up of serum TSH stimulating thyroglobulin (Tg) test and 131I whole body scan(WBS) in patients with differentiated thyroid cancer(DTC) who were treated by 131I.Methods By SPSS software,Kappa test was performed between results of serum Tg,TgAb test and WBS for diagnosis of persistent/recurrent DTC.Results Consistency test of TSH stimulating Tg,TgAb and 131I WBS for diagnostic persistent/recurrent or metastasis of DTC:kappa value =0.587,SE =0.076,P < 0.01.Although the results showed that two measurements appeared definite consistency,it is dissatisfactory.Conclusion Serum TSH stimulating Tg test and 131I whole body scan(WBS) are important follow-up tools for patients with DTC.Because of Tg interfering it is necessary to performed TgAb test simultaneously,when Tg test was performed.Especially 131I WBS do is not absent because false negative would be able to appeared in single serum TSH stimulating Tg and TgAb test.
5.Pharmacoeconomic comparisons of venlafaxine and mirtazapine in patients with treatment-resistant major depression
Yaguang WANG ; Zuowei WANG ; Chengmei YUAN ; Jun CHEN ; Zhiguo WU ; Yiru FANG
Chinese Journal of Behavioral Medicine and Brain Science 2014;23(4):327-330
Objective To compare the cost-effectiveness and cost-utility of venlafaxine and mirtazapine in patients with treatment-resistant major depression (TRD).Methods One hundred and five patients with TRD were enrolled in this study and grouped into venlafaxine treatment (n=50) and mirtazapine treatment (n=55) based on the double-blind randomization scheme generated by computer.The treatment costs of antidepressants during 8 weeks were calculated,the rates of clinical response and remission were taken as treatment effectiveness,and the quality-adjusted life years (QALYs) as treatment utility.The descriptive analysis and nonparametric test were used to compare the cost-effectiveness and cost-utility of different groups.Results During 8 weeks,the treatment cost of antidepressant was ¥ 1 396.44 for venlafaxine and ¥ 1 206.90 mirtazapine,and the difference between two groups was ¥ 189.54.The cost-effectiveness ratios between venlafaxine and mirtazapine were very close (differed ¥ 0.06 for remission rate and ¥ 1.08 for response rate respectively).There was no significant difference for cost-utility ratios between two groups (physical functioning Z=-0.15,P>0.05 ; mental health Z=-0.54,P>0.05).Conclusion Both cost-effectiveness and cost-utility of venlafaxine in patients with TRD are close between venlafaxine and mirtazapine.
6.HPLC Fingerprint of the Ingredients in Simiao Junyi Ointment
Qun HE ; Siyuan PENG ; Guangyu CHEN ; Shi WANG ; Yongheng HE ; Zuowei XIAO
China Pharmacist 2017;20(1):38-42
Objective:To establish an analytical method for HPLC fingerprint chromatography of Simiao Junyi ointment to provide basis for the quality control standard. Methods:The separation conditions were established to obtain the HPLC fingerprint chromatog-raphy of the main ingredients in Simiao Junyi ointment. The conditions were as follows:the chromatographic column was Ultimate C18-ODS(250 mm ×4.6 mm,5 μm), the mobile phase was acetonitrile-0.1% phosphate solution, the flow rate was 1.0 ml·min-1, the detection wavelength was 280 nm, and the column temperature was 35℃. The common peaks in the chromatography were analyzed for their belongings. Results:Gradient elution was performed under the above optimal separation conditions, the constituents in Simiao Ju-nyi ointment were separated from each other perfectly, and the optimal fingerprint chromatography was obtained. Though the methodolo-gy examination, the indicators such as precision, stability and repeatability of the method were all promising, and the fingerprint chro-matography could be seen clearly and was easy to be analyzed. The relationships between Simiao Junyi ointment and the common peaks of four medicinal materials in the fingerprint chromatography were preliminary determined, which provided important basis for the quali-ty control of Simiao Junyi ointment. Conclusion:The HPLC fingerprint chromatography of Simiao Junyi ointment can be used as an a-nalysis method for the quality control of Simiao Junyi ointment, which provides reference for the quality control standard for the finished product.
7.A comparsion study on the social functions promotion of different medicine treatment strategies on the patients with treatment-resistant depression
Weihong LU ; Chengmei YUAN ; Zhenghui YI ; Zuowei WANG ; Jun CHEN ; Zhiguo WU ; Wu HONG ; Yingyan HU ; Lan CAO ; Yiru FANG
Chinese Journal of Behavioral Medicine and Brain Science 2010;19(9):787-790
Objective To evaluate the effectiveness of different medicine treatment strategies on the social functions promotion on the patients with treatment-resistant depression (TRD). Methods 375 Patients with TRD were randomly grouped into 8 groups, and each group was received 8 weeks different treatment for paroxetine,venlafaxine, mirtazapine, paroxetine plus risperidone, paroxetine plus sodium valproate, paroxetine plus buspirone, paroxetine plus trazodone,or paroxetine plus thyroxine, respectively. The efficacy and social functions were evaluated with HAMD-17, SDSS and SF-36. Results There were significant difference in SDSS scores between 8th week and the baseline( P<0.01 ) , and for social functions factor scores of SF-36 there was significant difference between 4th ,8th week and the baseline in each groups( P<0.01 ). There were significant difference in social functions factor scores of SF-36 and subtracting scores between 4th and 8th week in all groups except group paroxetine and group venlafaxine(P < 0.05 or P < 0.01 ). There were significant difference in SDSS subtracting scores at 8th week among 8 groups( paroxetine plus risperidone group 7.05 ± 6.39, mirtazapine group 6.53 ± 4.75, paroxetine plusthyroxine group 5.14 ± 4.94, paroxetine group 5.13 ± 4.94 ,paroxetine plus trazodone group 5.00 ± 4.94, paroxetine plus sodium valproate group 4.60 ± 4.09, venlafaxine group 4.57 ± 4.18, paroxetine plus buspirone group 4.24 ± 4.95 ) ( Z = 2.076, P < 0.05 ), between group paroxetine plus risperidone and group venlafaxine , group paroxetine plus sodium valproate, group paroxetine plus buspirone,as group mirtazapine and group paroxetine plus buspirone(P< 0.05 ), respectively. The influencing factors on improving social functions are the severity, improvement of depressive symptoms and latest onset time. Conclusions These 8 treatment strategies all can promote social functions on the patients with TRD. But the intensity and chronological order of improvement werent the same among 8 groups. The influencing factors on improving social functions are the severity, improvement of depressive symptoms and latest onset time.
8.Dynamic changes of ATP binding cassette transporter A1 expression in perihematomal tissue of mouse cerebral hemorrhage model induced by collagenase
Xiangming TANG ; Zixuan CHEN ; Yingge WANG ; Hongmei CHEN ; Jiang XU ; Zuowei DUAN ; Xiaohong WANG ; Jingyan LIANG ; Xinjiang ZHANG
International Journal of Cerebrovascular Diseases 2018;26(9):689-695
Objective To investigate the ATP binding cassette transporter A1 (ABCA1) expression in perihematomal tissue of mouse cerebral hemorrhage model induced by collagenase. Methods Stereotactic injection of type Ⅳ collagenase was used to induce a model of caudate putamen intracerebral hemorrhage in mice. The behavioral scores were use to assess neurological deficits at 24 h, 48 h and 72 h after model making. Neisserian staining was used to detect the morphology of neurons around hematomas.Immunohistochemical staining and Western blot analysis were used to detect the expression of ABCA1 around hematomas. Results Nissl bodies reduction, atrophy, necrosis of perihematomal neurons were observed and aggravated over time. Immunohistochemical staining and Western blot analysis showed that the expression level of ABCA1 in the perihematomal tissue was significantly higher than that in the sham operation group (all P < 0. 05), and the expression level increased significantly with time (all P < 0. 05 ).Conclusion ABCA1 was up-regulated after cerebral hemorrhage, suggesting that it might be involved in the pathological process of cerebral hemorrhage.
9.The effect of assertive case management on relapse and health economic evaluation in schizophrenics living in communities
Jing ZHAO ; Qinyu LV ; Xiangqin GUO ; Guoqin HU ; Zuowei WANG ; Yaqin JIANG ; Jian CHEN ; Jubao LU ; Yi WU ; Hongtao XIE ; Zhenghui YI
Chinese Journal of Nervous and Mental Diseases 2014;(11):666-672
Objective To evaluate the effect of assertive case management on relapse and health economic evalua?tion in schizophrenics living in communities. Methods Two hundred outpatients were randomly divided into the study group (107 enrolled, 107 completed) which received assertive case management and the control group (93 enrolled, 91 completed) which received normal management treatment for 12 months. Clinical global impression scale (CGI) and the cost of treatment were assessed every three months. Medication adherence and family burden were evaluated before treat?ment and 3, 6 and 12 months after the treatment using Medication Adherence Rating Scale (MARS) and Family Burden Instructing, respectively. Results The study group was less likely to relapse compared with the control group over the 12-month follow-up and the relapse rates were 1.9%and 11.0%in study and control groups, respectively (P<0.01). The repeated-measures analysis of variance indicated that time main effect was significant in severity of illness factor score of CGI (P<0.01). The time main effect and group main effect in factor 1 and factor 3 scores of MARS were significant (all P<0.05) and there was an interaction effect in factor1 score of MARS (P<0.01). In the study group, time effect were signifi?cant in factor 1 score of MARS (P<0.01). The time main effects in indirect cost and total cost were significant and so were interaction effects in direct cost and total cost (P<0.05). In the study group, time effects were significant in direct cost and total cost (P<0.01). Comparison of FBI dimensions before and after the intervention showed that family relation?ship was much more decreased in the study group than in the control group (P<0.01). Conclusions Assertive Case Man?agement can reduce the recurrence of schizophrenia living in communities, improve compliance medication and family re?lationship as well as reduce the cost of treatment.
10.Correlation between serum miR-320b and carotid atherosclerosis in patients with acute ischemic stroke
Jiang XU ; Zixuan CHEN ; Yingge WANG ; Zuowei DUAN ; Xiangming TANG ; Tingting YUAN ; Yaoyao LU ; Hongmei CHEN ; Kunning YAN ; Jingyan LIANG ; Xinjiang ZHANG
International Journal of Cerebrovascular Diseases 2019;27(2):113-117
Objective To investigate the correlation between serum miR-320b and carotid atherosclerosis in patients with acute ischemic stroke.Methods From January 2017 to December 2017,patients with acute ischemic stroke visited the Department of Neurology,the Affiliated Hospital of Yangzhou University were enrolled.According to the findings of carotid artery ultrasonography,they were divided into plaque group and plaque-free group.The baseline clinical data such as demographic data,vascular risk factors,and blood biochemical indicators were collected.Reverse transcription quantitative polymerase chain reaction was used to detect the expression level of serum miR-320b.Multivariatelogistic regression analysis was used to determine the independent risk factors for carotid atherosclerosis.Results A total of 135 patients with acute ischemic stroke were enrolled in this study,including 58 females and 77 males,aged 58.4 ± 10.6 years.There were 85 patients in the plaque group and 50 in the plaque-free group.The total cholesterol (t =5.523,P =0.023) and low-density lipoprotein cholesterol (t =4.415,P =0.044) in the plaque group were significantly higher than those in the plaque-free group,while high-density lipoprotein cholesterol (t =5.849,P=0.017) and serum miR-320b (t =4.331,P=0.039) were significantly lower than those in the plaque-free group.Multivariate logistic regression analysis showed that referring to the highest quartile group,the low serum miR-320b level might be an independent risk factor for carotid atherosclerosis (the first quartile group:odds ratio 2.701,95% confidence interval 1.154-6.321,P =0.022;the second quartile group:odds ratio 2.521,95% confidence interval 1.249-5.091,P =0.010;and the third quartile group:odds ratio 1.849,95% confidence interval 1.041-3.283,P=0.036).Conclusion The low serum miR-320b level might be an independent risk factor for carotid atherosclerosis in patients with acute ischemic stroke.